N-Hydroxyurea—A versatile zinc binding function in the design of metalloenzyme inhibitors

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

N-Hydroxyurea binds both to carbonic anhydrase (CA) and to matrix metalloproteinases (MMPs). X-ray crystallography showed N-hydroxyurea to bind in a bidentate mode by means of the oxygen and nitrogen atoms of the NHOH moiety to the Zn(II) ion of CA, participating in a network of hydrogen bonds with a water molecule and Thr199. A derivatized N-hydroxyurea showed low-micromolar affinity for several CAs. This simple zinc binding function may be exploited for obtaining potent metalloenzyme inhibitors, due to its versatility of binding to the metal ion present in the active site of such enzymes.

Knowledge Graph

Similar Paper

N-Hydroxyurea—A versatile zinc binding function in the design of metalloenzyme inhibitors
Bioorganic & Medicinal Chemistry Letters 2006.0
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors
European Journal of Medicinal Chemistry 2008.0
Ninhydrins inhibit carbonic anhydrases directly binding to the metal ion
European Journal of Medicinal Chemistry 2021.0
Dual Inhibitors of Matrix Metalloproteinases and Carbonic Anhydrases: Iminodiacetyl-Based Hydroxamate−Benzenesulfonamide Conjugates
Journal of Medicinal Chemistry 2008.0
Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates
Bioorganic & Medicinal Chemistry 2007.0
Investigating the Selectivity of Metalloenzyme Inhibitors
Journal of Medicinal Chemistry 2013.0
New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Development of Potent Carbonic Anhydrase Inhibitors Incorporating Both Sulfonamide and Sulfamide Groups
Journal of Medicinal Chemistry 2012.0
Carbonic anhydrase inhibitors: Interactions of phenols with the 12 catalytically active mammalian isoforms (CA I–XIV)
Bioorganic & Medicinal Chemistry Letters 2008.0
Carbonic anhydrase inhibitors: Inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties
Bioorganic & Medicinal Chemistry Letters 2007.0